Baixar PDF

Outros usuários também visualizaram estes artigos

Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review Lauro Fabián Amador-Medina; Erick Crespo-Solís; Francisco Javier Turrubiates-Hernández; Karla Edith Santibañez-Bedolla;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S322-31
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents Maria Fernanda Lopes Carvalho; Bruna Oliveira de Almeida; Maura Lima Pereira Bueno; Hugo Passos Vicari; Keli Lima; Eduardo Magalhães Rego; Fernanda Marconi Roversi; João Agostinho Machado-Neto;
Hematol Transfus Cell Ther. 2024;46:273-82
Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation Mariane Cristina do Nascimento; Diego A. Pereira-Martins; João Agostinho Machado-Neto; Eduardo M. Rego;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S48-52